Variants of renin-angiotensin system genes and echocardiographic left ventricular mass

European Heart Journal

Volumn 19, Issue 7, 1998, Pages 1109-1117

  Kauma, Heikki ^a   Ikaheimo M ^a   Savolainen, M J ^a   Kiema, T R ^a   Rantala, A O ^a   Lilja, M ^a   Reunanen, A ^b   Kesaniemi Y A ^a  

^a UNIVERSITY OF OULU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Angiotensin; Angiotensin converting enzyme; Genetics; Ventricular hypertrophy

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; FEMALE; GENETIC VARIABILITY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ALLELES; ANGIOTENSINOGEN; CARDIAC VOLUME; CASE-CONTROL STUDIES; CHROMOSOME DELETION; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; VARIATION (GENETICS);

EID: 0032126355     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.0155     Document Type: Article

References (62)

1. [1] Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: the Framingham Study. Ann Intern Med 1970; 72: 813-22.
2. [2] Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Study. N Engl J Med 1990; 322: 1561-6.
3. [3] Sullivan JM, Vander Zwaag RV, el-Zeky F, Ramanathan KB, Mirvis DM. Left ventricular hypertrophy: effect on survival. J Am Coll Cardiol 1993; 33: 508-13.
4. [4] Beaglehole R, Tyroler HA, Cassell LC, Deubner DC, Bartel AG, Hames CG. An epidemiological study of left ventricular hypertrophy in the biracial population of Evans County, Georgia. J Chronic Dis 1974; 28: 549-59.
5. [5] Liebson PR, Grandits G, Prineas R et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the treatment of mild hypertension study (TOMHS). Circulation 1993; 87: 476-86.
6. [6] Kannel WB, Dannenberg AL, Levy D. Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol 1987; 60: 851-931.
7. [7] Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors: the Framingham Heart Study. Ann Intern Med 1988; 108: 7-13.
8. [8] Schmeider RE, Messerli FH, Garavaglia GE, Nunez BE. Dietary salt intake: a determinant of cardiac involvement in essential hypertension. Circulation 1988; 78: 951-6.
9. [9] Manolio TA, Levy D, Garrison J, Castelli WP, Kannel WB. Relation of alcohol intake to left ventricular mass: the Framingham Heart Study. J Am Coll Cardiol 1991; 17: 717-21.
10. [10] Sasson Z, Rasooly Y, Bhesania T, Rasooly I. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993; 88: 1431-6.
11. [11] Marcus R, Krause L, Weder AB, Dominguez-Mejia A, Schork NJ, Julius S. Sex-specific determinants of increased left ventricular mass in the Tecumseh blood pressure study. Circulation 1994; 90: 928-36.
12. [12] Verhaaren HA, Schicken RM, Mosteller M, Hewitt JK, Eaves LJ, Nance WE. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia Twin Study). Am J Cardiol 1991; 68: 661-8.
13. [13] Himmelmann A, Svensson A, Hansson L. Blood pressure and left ventricular mass in children with different maternal histories of hypertension: the Hypertension in Pregnancy Offspring Study. J Hypertens 1993; 11: 263-8.
14. [14] Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens 1991; 9: 3-15.
15. [15] Weber KT, Brilla CG, Campbell SE, Zhou G, Matsubaru L, Guarda E. Pathological hypertrophy with fibrosis: the structural basis for myocardial failure. Blood Pressure 1992; 1: 75-85.
16. [16] Ehlers MRW, Riordan JF. Angiotensin-con verting enzyme: new concepts concerning its biological role. Biochemistry 1989; 28: 5311-7.
17. [17] Danser AHJ, Schalekamp ADH. Is there an internal cardiac renin-angiotensin system? Heart (Suppl 3) 1996; 76: 28-32.
18. [18] Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest 1990; 86: 1913-20.
19. [19] Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
20. [20] Raynolds MV, Bristow MR, Bush EW et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1073-5.
21. [21] Tiret L, Kee F, Poirier O et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993; 341: 991-2.
22. [22] Schunkert H, Hense H-W, Holmer SR et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-8.
23. [23] Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90: 2622-8.
24. [24] Nakai K, Itoh C, Miura Y et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994; 90: 2199-2202.
25. [25] Mattu RK, Needham EWA, Gallon DJ, Frangos E, Clark AJL, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly heart study. Circulation 1995; 91: 270-4.
26. [26] Gardemann A, Weiß T, Schwartz O et al. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation 1995; 92: 2796-9.
27. [27] Ohishi M, Fujii K, Minamino T et al. A potent genetic risk factor for restenosis. Nature Genetics 1993; 5: 324-5.
28. [28] Castellano M, Muiesan ML, Rizzoni D et al. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. Circulation 1995; 91: 2721-4.
29. [29] Kauma H, Päivänsalo M, Savolainen MJ et al. Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis. J Hypertens 1996; 14: 1183-7.
30. [30] Bøhn M, Berge KE, Bakken A, Erikssen J, Berk K. Insertion/ deletion (I/D) polymorphism at the locus for angiotensin-I converting enzyme and myocardial infarction. Clin Genet 1993; 44: 292-7.
31. [31] Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ. Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymophorism in humans. Am J Physiol 1994; 267: H1107-11.
32. [32] Miettinen HE, Korpela K, Hämäläinen L, Kontula K. Polymorphism of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet 1994; 94: 189-92.
33. [33] Lindpaintner K, Pfeffer MA, Kreutz R et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-11.
34. [34] Lindpaintner K, Lee M, Larson MG et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996; 334: 1023-8.
35. [35] Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6.
36. [36] Tiret L, Rigat B, Visvikis S et al. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.
37. [37] Danser AHJ, Schalekamp MADH, Bax WA et al. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-8.
38. [38] Jeunemaitre X, Soubrier F, Kotelevtsev YV et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-80.
39. [39] Hata A, Namikawa C, Sasaki M et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93: 1285-7.
40. [40] Caulfield M, Lavender P, Farrall M et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330: 1629-33.
41. [41] Borecki IB, Province MA, Ludwig EH et al. Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: The NHLBI family heart study. Ann Epidemiol 1997; 7: 13-21.
42. [42] Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995; 25 [part 2]: 688-93.
43. [43] Lindpaintner K, Lu W, Niedermajer N et al. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol 1993; 25: 133-43.
44. [44] Gharavi AG, Lipkowitz MS, Diamond JA, Jhang JS, Phillips RA. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am J Cardiol 1996; 77: 1315-9.
45. [45] Perticone F, Ceravolo R, Cosco C et al. Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in Southern Italian patients. J Am Coll Cardiol 1997; 29: 365-9.
46. [46] Ohmichi N, Iwai N, Maeda K et al. Genetic basis of left ventricular remodeling after myocardial infarction. Int J Cardiol 1996; 53: 265-72.
47. [47] Bigda J, Chrostowska M, Jagoda J et al. Left ventricular mass is related to genetic variation at the angiotensinogen locus in normotensive subjects (Abstr). Eur Heart J (Abstr Suppl) 1996; 17: 95.
48. [48] Kiema T-R, Kauma H, Rantala AO et al. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996; 28: 1070-5.
49. [49] Grimby G. Physical activity and muscle training in the elderly. Acta Med Scand 1986; 711 (Suppl): 233-7.
50. [50] Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
51. [51] Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxy-peptidase 1). Nucleic Acids Res 1992; 20: 1433.
52. [52] Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Applications 1993; 3: 120-1.
53. [53] Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin NC. ACE gene typing. Lancet 1994; 343: 851.
54. 235→Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993; 2: 609-10.
55. [55] Sahn DJ, DeMaria A, Kisslo J, Weyman A. Committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography; results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
56. [56] Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-8.
57. [57] Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-71.
58. [58] Devereux RB, Lutas EM, Casale PN et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4: 1222-30.
59. [59] Cooper DN, Clayton JF. DNA polymorphism and the study of disease associations. Hum Genet 1988; 78: 299-312.
60. [60] Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation 1981; 63: 1391-8.
61. [61] Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings: standards and procedures for measurement and classification. Littleton, Mass., USA: John Wright/PSG, 1982.
62. [62] West MJ, Summers KM, Burstow DJ, Wong KK, Huggard PR. Renin and angiotensin-converting enzyme genotypes in patients with essential hypertension and left ventricular hypertrophy. Clin Exp Pharmacol Physiol 1994; 21: 207-10.